Short answer
ANI PHARMACEUTICALS INC (ANIP) filed an 8-K current report with the SEC on May 8, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Filing contains only the signature page, not substantive Item 2.02 earnings information.
ANI PHARMACEUTICALS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Filing contains only the signature page, not substantive Item 2.02 earnings information
- Dated May 8, 2026 and signed by Stephen P. Carey, Senior Vice President Finance and CFO
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ANI PHARMACEUTICALS INC 8-K filings
Get the next ANIP 8-K as it lands
Follow ANIP for push alerts, or ask the research agent what this filing means.